Trials Sponsors Conditions Drugs Pricing

Conditions

Stress Incontinency

Keywords

transplantation autologous stress urinary incontinencemuscle derived cells

Outcome Measures

Primary Outcomes (1)

24hours voiding diary reduction
Evaluation the 24hours voiding diary reduction by patient questionaire 2h pad test and By clinical measures by cystourethroscopy and urodynamic before , 1, 3,6 and 12 months after MDCs injection.
1month

Secondary Outcomes (1)

Enhance incontinence quality of life (I-Qol)
1 month

Study Arms (1)

MDCs transplant

EXPERIMENTAL

The women who have stress urinary incontinency.

Biological: paraurethral injection of MDCs

Interventions

paraurethral injection of MDCsBiological

MDCs transplantation by paraurethral injection .

Also known as: MDCs transplantion by paraurethral injection.

MDCs transplant

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age40 Years - 65 Years

Sexfemale

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Female
Stress Urinary Incontinence symptoms

Sponsors & Collaborators

Royan Institute
Governmentlead

Study Sites (1)

Royan Institute

Tehran, Iran

Study Officials

Hamid Gourabi, PhD
Head of Royan Institute
STUDY CHAIR
Nasser Aghdami, MD,PhD
Head of Department of Regenerative Medicine And Royan Cell Therapy Center Royan Institute For stem Cell Biology and Technology
STUDY DIRECTOR
Farzaneh Sharifiaghdas, MD
Urology and Nephrology Research Center, Shahid Beheshti University
STUDY DIRECTOR
Reza Moghadasali, PhD
Department of Regenerative Medicine And Royan Cell Therapy Center Royan Institute For stem Cell Biology and Technology
PRINCIPAL INVESTIGATOR

Study Design

Study Type: interventional
Phase: phase 1
Allocation: NA
Masking: NONE
Purpose: TREATMENT
Intervention Model: SINGLE GROUP
Sponsor Type: OTHER GOV
Responsible Party: SPONSOR

Study Record Dates

First Submitted

October 10, 2013

First Posted

October 16, 2013

Study Start

January 2013

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

August 2014

Actual (reported)

Autologous Muscle Derived Stem Cells Transplantation in Urine Incontinency

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (1)

MDCs transplant

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Links

Study Officials

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (1)

MDCs transplant

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Links

Study Officials

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations